Coates, Laura C. http://orcid.org/0000-0002-4756-663X
Wallman, Johan K.
McGonagle, Dennis
Schett, Georg A.
McInnes, Iain B.
Mease, Philip J.
Rasouliyan, Lawrence
Quebe-Fehling, Erhard
Asquith, Darren L.
Fasth, Andreas E. R.
Pricop, Luminita
Gaillez, Corine
Funding for this research was provided by:
Novartis Pharma AG (None)
Article History
Received: 31 May 2019
Accepted: 8 November 2019
First Online: 4 December 2019
Ethics approval and consent to participate
: The FUTURE 2 and FUTURE 3 studies were conducted in compliance with the Declaration of Helsinki (World Medical Association, 2013), International Council for Harmonization Guidelines for Good Clinical Practice, and local country regulations. Studies were approved by institutional review boards or independent ethics committees at each participating center. Written informed consent was obtained from all enrolled patients.
: All authors provide their consent for publication of this revised version of the manuscript in the <i>Arthritis Research & Therapy</i> journal.
: LC Coates: Grant/research support from AbbVie, Pfizer, Novartis, Lilly, Celgene and Janssen; Consultant for AbbVie, Amgen, Biogen, Boehringer Ingelheim, Celgene, Gilead, Galapagos, Pfizer, UCB, Novartis, Lilly and JanssenJK Wallman: Consultant for: AbbVie, Celgene, Lilly, Novartis, UCBD McGonagle: Grant/research support from: Novartis, Janssen, Pfizer, AbbVie, Lilly; Speakers bureau: Novartis, Janssen, Pfizer, AbbVie, Lilly, UCBG Schett: Grant/research support from: BMS, Celgene, GSK, Lilly, Novartis; Consultant for: AbbVie, BMS, Celgene, Janssen, Lilly, Novartis, UCB; Speakers bureau: AbbVie, BMS, Celgene, Janssen, Lilly, Novartis, PfizerIB McInnes: Grant/research support from: AbbVie, Amgen, BMS, Celgene, Janssen, Lilly, Novartis, Pfizer, UCB; Consultant for: AbbVie, Amgen, BMS, Celgene, Janssen, Lilly, Novartis, Pfizer, UCB; Speakers bureau: AbbVie, Amgen, BMS, Celgene, Janssen, Lilly, Novartis, Pfizer, UCBPJ Mease: Grant/research support from AbbVie, Amgen, BMS, Celgene, Crescendo Bioscience, Genentech, Janssen, Lilly, Merck, Novartis, Pfizer and UCB; Consultant for AbbVie, Amgen, BMS, Celgene, Crescendo Bioscience, Genentech, Janssen, Lilly, Merck, Novartis, Pfizer and UCB; Speakers bureau for AbbVie, Amgen, BMS, Celgene, Crescendo Bioscience, Genentech, Janssen, Lilly, Merck, Novartis, Pfizer and UCBL Rasouliyan: Consultant for: Novartis through employment at RTI, Employee of: RTI Health SolutionsE Quebe-Fehling: Shareholder and employee of NovartisDL Asquith: Shareholder and employee of NovartisAER Fasth: Employee of NovartisL Pricop: Shareholder and employee of NovartisC Gaillez: Shareholder and employee of Novartis and Shareholder of BMS